Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koen van Besien

Showing results (81-90 of 241) with videos related to

Pageof 25
Sort By:
Leukemia & Lymphoma|October 20, 2021
Use of eculizumab in autologous hematopoietic stem cell transplantation-associated thrombotic microangiopathy in two adultsMohammad Alhomoud, Aquino Williams, Cynthia Magro, et al.
Blood|May 25, 2004
Irreversible myelosuppression after fludarabine-melphalan conditioning: observations in patients with graft rejectionKoen Van Besien, Sonali Smith, John Anastasi, et al.
Leukemia & Lymphoma|January 31, 2019
The application of precision medicine in diagnosing familial Mediterranean feverShannon Glynn, Steven Lipkin, Tuo Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2008
Paucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor optionsAlexander Dew, Demetria Collins, Andrew Artz, et al.
Cytokine|November 15, 2012
Distinct functions of erythropoietin and stem cell factor are linked to activation of mTOR kinase signaling pathway in human erythroid progenitorsRenaud Geslain, Shahab Uddin, Hui Liu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 3, 2015
Comparison of Subcutaneous versus Intravenous Alemtuzumab for Graft-versus-Host Disease Prophylaxis with Fludarabine/Melphalan-Based Conditioning in Matched Unrelated Donor Allogeneic Stem Cell TransplantationKhilna Patel, Sapna Parmar, Shreya Shah, et al.
Leukemia & Lymphoma|April 19, 2019
Combined use of tofacitinib (pan-JAK inhibitor) and ruxolitinib (a JAK1/2 inhibitor) for refractory T-cell prolymphocytic leukemia (T-PLL) with a JAK3 mutationAlexandra Gomez-Arteaga, Elizabeth Margolskee, Mike T Wei, et al.
Oncology Nursing Forum|May 6, 2006
Fatigue and physical activity in patients undergoing hematopoietic stem cell transplantEileen Hacker Danaher, Carol Ferrans, Ellen Verlen, et al.
Transfusion|December 15, 2015
Engraftment for CD34 selected stem cell products is not compromised by cryopreservationRonit Reich-Slotky, Lohith S Bachegowda, Michael Ancharski, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|June 17, 2022
Now you see me, now you don't: Isolated central nervous system recurrence of CD19-negative diffuse large B-cell lymphoma following CD19-directed CAR T-cell treatmentHamza N Gokozan, Madhu M Ouseph, Jose V Scarpa Carniello, et al.
Pageof 25

Showing results (81-90 of 241) with videos related to

Sort By:
Pageof 25
Leukemia & Lymphoma|October 20, 2021
Use of eculizumab in autologous hematopoietic stem cell transplantation-associated thrombotic microangiopathy in two adultsMohammad Alhomoud, Aquino Williams, Cynthia Magro, et al.
Blood|May 25, 2004
Irreversible myelosuppression after fludarabine-melphalan conditioning: observations in patients with graft rejectionKoen Van Besien, Sonali Smith, John Anastasi, et al.
Leukemia & Lymphoma|January 31, 2019
The application of precision medicine in diagnosing familial Mediterranean feverShannon Glynn, Steven Lipkin, Tuo Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2008
Paucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor optionsAlexander Dew, Demetria Collins, Andrew Artz, et al.
Cytokine|November 15, 2012
Distinct functions of erythropoietin and stem cell factor are linked to activation of mTOR kinase signaling pathway in human erythroid progenitorsRenaud Geslain, Shahab Uddin, Hui Liu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 3, 2015
Comparison of Subcutaneous versus Intravenous Alemtuzumab for Graft-versus-Host Disease Prophylaxis with Fludarabine/Melphalan-Based Conditioning in Matched Unrelated Donor Allogeneic Stem Cell TransplantationKhilna Patel, Sapna Parmar, Shreya Shah, et al.
Leukemia & Lymphoma|April 19, 2019
Combined use of tofacitinib (pan-JAK inhibitor) and ruxolitinib (a JAK1/2 inhibitor) for refractory T-cell prolymphocytic leukemia (T-PLL) with a JAK3 mutationAlexandra Gomez-Arteaga, Elizabeth Margolskee, Mike T Wei, et al.
Oncology Nursing Forum|May 6, 2006
Fatigue and physical activity in patients undergoing hematopoietic stem cell transplantEileen Hacker Danaher, Carol Ferrans, Ellen Verlen, et al.
Transfusion|December 15, 2015
Engraftment for CD34 selected stem cell products is not compromised by cryopreservationRonit Reich-Slotky, Lohith S Bachegowda, Michael Ancharski, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|June 17, 2022
Now you see me, now you don't: Isolated central nervous system recurrence of CD19-negative diffuse large B-cell lymphoma following CD19-directed CAR T-cell treatmentHamza N Gokozan, Madhu M Ouseph, Jose V Scarpa Carniello, et al.
Pageof 25